| To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome B Mefford, JC Donaldson, BD Bissell Annals of Pharmacotherapy 54 (9), 899-906, 2020 | 25 | 2020 |
| Platelet Function Testing with a VerifyNow-Directed Personalized Antiplatelet Strategy and Associated Rates of Thromboembolic Complications After Pipeline Embolization for … R Neyens, C Donaldson, C Andrews, R Kellogg, A Spiotta World neurosurgery 138, e674-e682, 2020 | 13 | 2020 |
| Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review M Behal, B Barlow, B Mefford, MLT Bastin, JC Donaldson, M Laine, ... Critical Care Explorations 3 (7), 2021 | 8 | 2021 |
| Ascorbic acid in the acute care setting C Kressin, K Pandya, BM Woodward, C Donaldson, AH Flannery Journal of Parenteral and Enteral Nutrition 45 (5), 874-881, 2021 | 7 | 2021 |
| A narrative review of pharmacologic de-resuscitation in the critically ill BD Bissell, JC Donaldson, PE Morris, JA Neyra Journal of Critical Care 59, 156-162, 2020 | 7 | 2020 |
| The immunomodulatory effects of opioids and implications for intensive care unit populations B Mefford, JC Donaldson, BD Bissell Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41 (8 …, 2021 | 4 | 2021 |
| Managing Acute Pain in Opioid Use Disorder B Mefford, JC Donaldson US Pharm 42, 2022 | 1 | 2022 |
| Comment: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk. BD Bissell, B Mefford, JC Donaldson The Annals of Pharmacotherapy 56 (4), 505-506, 2021 | 1 | 2021 |
| Alleviating Androgenic Alopecia BM Mefford, JC Donaldson US Pharm 48 (6), 8-12, 2023 | | 2023 |
| Treating Medication-Induced Pruritus BM Mefford, JC Donaldson US Pharm 47 (8), 43-46, 2022 | | 2022 |
| 1093: IMPACT OF PRONING ON PARALYZED PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME A Wiegand, MT Bastin, A Cole, A Schadler, T Gray, JC Donaldson, ... Critical Care Medicine 50 (1), 545, 2022 | | 2022 |
| 889: AKI WITH AUC VERSUS TROUGH-GUIDED VANCOMYCIN MONITORING WITH CONCOMITANT BETA-LACTAMS IN THE ICU B Mefford, C Donaldson, B Bissell, K Wallace, P Sen, MT Bastin Critical Care Medicine 50 (1), 440, 2022 | | 2022 |
| 259: PHARMACOKINETIC INFLUENCE OF TOCILIZUMAB ON MIDAZOLAM IN CRITICALLY ILL PATIENTS WITH COVID-19 B Mefford, C Donaldson, B Bissell Critical Care Medicine 50 (1), 114, 2022 | | 2022 |
| Analgesia and Sedation Strategies in COVID-19 Patients BM Mefford, JC Donaldson Us Pharmacist, HS11-+, 2021 | | 2021 |
| 773: EVALUATION OF ANTIPLATELET RESPONSE AND RATES OF THROMBOSIS FOLLOWING NEUROENDOVASCULAR STENTING C Donaldson, R Neyens Critical Care Medicine 47 (1), 365, 2019 | | 2019 |
| 1509: IMPACT OF IV PUSH ANTIBIOTICS ON TIME TO EMPIRIC ANTIBIOTIC ADMINISTRATION IN SEPTIC PATIENTS C Donaldson, M Rech, E Sterk Critical Care Medicine 46 (1), 738, 2018 | | 2018 |
